Impact of human papillomavirus (HPV) self-collection on subsequent cervical cancer screening completion among under-screened US women: MyBodyMyTest-3 protocol for a randomized controlled trial.

MLA

Spees, Lisa P., et al. “Impact of Human Papillomavirus (HPV) Self-Collection on Subsequent Cervical Cancer Screening Completion among under-Screened US Women: MyBodyMyTest-3 Protocol for a Randomized Controlled Trial.” Trials, vol. 20, no. 1, Dec. 2019, pp. 1–11. EBSCOhost, https://doi.org/10.1186/s13063-019-3959-2.

APA

Spees, L. P., Des Marais, A. C., Wheeler, S. B., Hudgens, M. G., Doughty, S., Brewer, N. T., & Smith, J. S. (2019). Impact of human papillomavirus (HPV) self-collection on subsequent cervical cancer screening completion among under-screened US women: MyBodyMyTest-3 protocol for a randomized controlled trial. Trials, 20(1), 1–11. https://doi.org/10.1186/s13063-019-3959-2

Chicago

Spees, Lisa P., Andrea C. Des Marais, Stephanie B. Wheeler, Michael G. Hudgens, Sarah Doughty, Noel T. Brewer, and Jennifer S. Smith. 2019. “Impact of Human Papillomavirus (HPV) Self-Collection on Subsequent Cervical Cancer Screening Completion among under-Screened US Women: MyBodyMyTest-3 Protocol for a Randomized Controlled Trial.” Trials 20 (1): 1–11. doi:10.1186/s13063-019-3959-2.